February 26, 2024
GLP-1s are drugs proven to treat diabetes. But with high costs, increased use for other purposes and clinical uncertainty, GLP-1s are not without controversy. This brief underscores the history of these medications and makes policy recommendations to ensure patients are receiving the right drugs at the right time.
New from ACHP:
- Overcoming Barriers: Transforming Black Maternal Health Through Research Webinar
- PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast
- OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
- ACHP Statement on Final Rule for Medicare Advantage and Part D
- WEBINAR: Medicare Advantage in 2024 and Beyond
- ACHP Joins First Lady Jill Biden and Health Care Leaders to Support Cancer Moonshot Initiative
